May 06, 2016
1 min read
Save

Dermatologic surgeons performed nearly 10 million skin cancer, aesthetic procedures in 2015

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Dermatologic surgeons performed nearly 10 million skin cancer treatments and cosmetic procedures in 2015, according to survey results released by the American Society for Dermatologic Surgery.

The number of procedures in 2015 was a 5% increase from 2014 and a 27% increase from 2012, according to a press release from the ASDS.

Skin cancer treatments were ranked as the most performed procedure by ASDS members, with 3.17 million treatments, an 18% increase since 2012.

There were 6.7 million cosmetic procedures performed by ASDS members in 2015, with soft-tissue fillers experiencing a 35% year-to-year growth and body sculpting increasing 11% from 2014.

Top cosmetic procedures in 2015 included 2.62 million laser, light and energy procedures; 1.79 million neuromodulators; 1.36 million soft-tissue fillers; 596,000 chemical peels; and 230,000 body sculpting treatments, according to the release.

Study results recently published in Dermatologic Surgery found “dermatologists as the premier innovators in 14 of 18 cosmetic treatment categories,” according to the release.

Naomi Lawrence, MD

Naomi Lawrence

“With the growing popularity of noninvasive cosmetic treatments, this pioneering research can help consumers decide which specialist might be the optimal provider of a certain procedure,” Naomi Lawrence, MD, ASDS president, stated in the release. “These research results reinforce why the public should trust dermatologists above all others for cosmetic medical guidance.”

There were 218,000 procedures performed by ASDS members for melanoma in 2015, a 5% increase from 2014, according to the release. There was a slight increase in treatments for non-melanoma skin cancer.

The survey data were generalized to represent all ASDS members, with the survey conducted between Jan. 4 and Feb. 5, 2016, The survey was sent to 3,832 practicing members of ASDS, with 563 physicians responding, for a response rate of 14.7%, according to the release.

Reference:  www.asds.net